Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0002064832-26-000006

President and CEO gave up 6,155 shares (to pay taxes)

  • President and CEO acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Luly Jay R. · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-12 Grant or award : show line 1 in the form +4,800 862,826 D
2026-02-12 Grant or award : show line 2 in the form +15,200 878,026 D
2026-02-12 Shares withheld for taxes : show line 3 in the form −6,155 $14.25 $87,709 871,871 D
Loading xslF345X05/form4.xml…